Clever Leaves

sustainable, high-efficiency, large-scale cultivation and extraction of cannabinoids

PROJECT CHANGE LIVES

Clever Leaves

sustainable, high-efficiency, large-scale cultivation and extraction of cannabinoids

PROJECT CHANGE LIVES

Clever Leaves

producer of pharmaceutical and consumer cannabis brands

PROJECT CHANGE LIVES
Clever Leaves

ABOUT US

Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was also granted certification of compliance with GACP and IMC-GAP.

Genetics

Diverse strain portfolio and unique breeding capabilities​

Cultivation

Sustainable, high-efficiency and large-scale to meet rapidly growing global demand

Extraction

Industrial, high-efficiency extraction and product formulation

Research & development

Scientific-Based Innovative Products and Processes

Wholesale & Distribution

Global provider of isolate, full spectrum, and white label products

Brands

Recognizable and trusted medical and consumer brands

OUR LEADERSHIP TEAM

KYLE DETWILER

Chief Executive Officer

ANDRÉS FAJARDO

President

HANK HAGUE

Chief Financial Officer

JULIÁN WILCHES

Chief Regulatory Officer

DAVID M. KASTIN

General Counsel and Corporate Secretary

GUSTAVO ESCOBAR

Head of Commercial: Latin America

ANDREW MILLER

Head of Commercial: Global (Ex-LatAm)

CAROLINE KLIESS

Managing Director
(Germany)

Our mission is to be the industry leading global cannabis company recognized for our principles, people, and performance while fostering a healthier global community.

our values

Cultivate Mojo. Create Value. Change Lives.

WHAT WE DO

Clever Leaves is dedicated to the innovation, development and commercialization of pharmaceutical grade cannabis. By partnering with local governments and regulators around the world, we are building the pathways of a legal and fully global medical cannabis ecosystem.  We believe in the power of medical cannabis and are dedicated to advancing this cause for our patients and helping improve their quality of life.

Our consumer brands division is focused around creating and distributing best in class products around the world.  Clever Leaves is utilizing our global cannabinoid production and distribution capabilities to take advantage of the growing popularity of hemp derived CBD products.  With opportunities in the wellness, lifestyle and beauty segments we believe consumers will aggregate towards brands that can control and trace the entire product’s supply chain, giving Clever Leaves a real advantage. We are building out a global branded portfolio both through acquisition as well as internal brand development. 

HERBAL BRANDS INC. is an Arizona based manufacturer and distributor of health and wellness products. The HERBAL BRANDS portfolio includes a number of nutraceutical and beverage brands that sell in over 10,000 retail locations across the United States.

Clever Leaves’ large scale cultivation and extraction facilities have allowed us to become a large wholesale supplier of cannabinoids to companies around the world.  Our GMP certified extracted products are available in multiple forms, including raw material formats such as: crude oils, distillates and isolates, as well as finished products through our white label manufacturing capabilities.

In the rapidly evolving global cannabis marketplace, Clever Leaves believes in partnering and investing in best in class companies, and has made a number of strategic investments which help enable our global vision. Clever Leaves’ investment professionals have collectively invested in excess of $3b of capital at leading investment institutions and have a track record in navigating and executing in complex, regulated and evolving marketplace environments.

CANSATIVA is a Frankfurt based certified importer and distributor of medical cannabis products throughout Germany. Our investment in CANSATIVA enables access and distribution of IQANNA products throughout the German medical marketplace

GLOBAL FOOTPRINT

Clever Leaves is a Global Company with offices in Canada, Colombia, Germany, Portugal and United States. We have raised $100 million of capital and are focused on new development projects, leveraging best practices from other industries to build sophisticated, EuGMP cannabis assets.

 

CLEVER LEAVES IN THE NEWS

The Colombian President Iván Duque visits Clever Leaves’ cultivation facility in Pesca, Colombia

See the event of the signing of the Decree for the Safe and Informed Use of Cannabis via Presidencia de la República – Colombia

CONTACT THE PR TEAM

If you are a member of the media and have news-related inquiries for Clever Leaves, please contact:

Diana Sigüenza

Strategic Communications Director

diana.siguenza@cleverleaves.com

Mckenna Miller

KCSA Strategic Communications

mmiller@kcsa.com

CONTACT US

     

    CAROLINE KLIESS

    Managing Director (Germany)

    Caroline, with German and French nationality, brings a proven success record in the German pharma and medical cannabis markets. Prior to Clever Leaves, Caroline served as Director of Sales & Operations at Tilray Germany where she launched the first medical cannabis extracts into the German market after the 2017 law change. After studying Pharmacy at the University of Hamburg, Caroline also held multiple leadership positions during her 15-year tenure at Astra Zeneca Germany, from regional sales management to commercial head of oncology, leading teams of 150 employees. With 20 years of operational leadership experience in the pharmaceutical industry, covering disease areas such as Asthma, COPD, Diabetes, Pain, Cardiovascular and Gastro-intestinal disease, Caroline brings structured, commercial pharma expertise together with individualized medicine approaches needed in a broad range of indications.

     

    HANK HAGUE

    Chief Financial Officer

    Hank Hague is the Chief Financial Officer for Clever Leaves. Hank has extensive experience in providing financial leadership to various public and private entities in the pharmaceutical, biomedical, and cannabis industries. Most recently, Hank served as CEO at Aidance Scientific, an FDA-registered manufacturer of branded and private label OTC topical medications. Prior to this role, Hank was CFO of Abacus Health Products where he led the company’s public listing and the acquisition and integration of Harmony Hemp. Hank also managed the due diligence and sale process of Abacus to hemp-derived wellness product producer and distributor, Charlotte’s Web Holdings, Inc. Additionally, Hank has held CFO roles at Foster Corporation and Scott Brass. Hank graduated from Bentley University with a bachelor’s degree in finance.

    ANDREW MILLER

    Head of Commercial: Global (Ex-LatAm).

    Andrew is Head of Commercial: Global (Ex-LatAm) for Clever Leaves. Andrew has more than 20+ years experience advising executives and companies on accelerating financial and operational growth in industries such as Cannabis, Pharmaceuticals, Healthcare, Medical Devices, Banking and Not-for-profit organizations. Before joining Clever Leaves, Andrew advised more than 100 companies around the world, including 3M, Four Seasons Hotel and Resorts, The Bank of Nova Scotia, Philips, Becton Dickinson, and the YMCA on developing and implementing successful growth strategies.Miller has written two commercially published books as a key player in operational excellence: “Redefining Operational Excellence” (AMACOM, 2014), and “The Unified Theory of Profitability” (Business Expert Press, 2016).

    For business inquiries, please contact Andrew at andrew.miller@cleverleaves.com

    DAVID M. KASTIN

    General Counsel and Corporate Secretary

    David M. Kastin is the General Counsel and Corporate Secretary of Clever Leaves where he leads the company’s global legal and compliance function. David joins Clever Leaves from The Vitamin Shoppe, a omni-channel specialty retailer, where he served as the General Counsel and Corporate Secretary. David has more than 25 years' experience and a proven track record of success in the legal profession with experience in representing companies in all facets of their business.  Previously, he served as General Counsel and Corporate Secretary at Town Sports International Holdings, Inc., a leading owner and operator of health and fitness clubs in the Northeast, United States, Deputy General Counsel at Toys "R" Us, Inc., and worked at several prominent New York law firms, including Bryan Cave LLP.  He began his career as Staff Attorney in the Northeast Regional Office of the U.S. Securities and Exchange Commission.

    David graduated from The George Washington University, in Washington, D. C. with a degree in Finance and graduated from The Benjamin N. Cardoza School of Law, with a J.D. degree and is a member of the New York and New Jersey bar.

    GUSTAVO ESCOBAR

    Head of Commercial: Latin America

    Gustavo is the Commercial Director for Latin America, responsible for the development of commercial businesses and other strategic alliances in the region, which are gaining more relevance in markets that have adapted pharmaceutical models that include the legalization of medical cannabis.

    Gustavo was responsible for the creation and construction process of the company in the first 3 initial years and was able to establish the operational footprint of Clever Leaves in Colombia. He then led the innovation projects, the development of the first products, and the genetic developments that guaranteed the initial offering of the company's portfolio. Hence, he became in charge of designing and implementing the company's innovation projects while creating a tangible differentiation in the market through a high impact business model.

    Gustavo was promoter and co-founder of Asocolcanna (Colombian Association of the Cannabis Industry), where, for the first two years of operation, he held the position of the president of its Board of Directors.

    Prior to Clever Leaves, Gustavo was a founding partner of Mojo Ventures, a startup company focused on generating growth with unprecedented returns.

    With a professional career of over 18 years, Gustavo combines his corporate experience with his entrepreneurship skills. For 12 years he was part of the IQ team, Sanford Group in Colombia, executing management functions, contributing to international expansion, leading commercial management, and implementing technology-based projects primarily in the health sector. Additionally, he has experience in providing services to the financial, telecommunications, agrobusiness, and pharmaceutical sectors.

    Gustavo holds an MBA from Universidad de los Andes and a B.E. degree in Information Technology Engineering from Pontificia Universidad Javeriana.

    ANDRÉS FAJARDO

    President

    Andres is President at Clever Leaves. He has led the development of its first 18 Hectares of GACP and EU-GMP certified cultivation and post-harvest facilities, the design and construction of a GMP certified extraction and formulation plant, and the development of a robust pipeline of clients and brands. Prior to Clever Leaves, Andres was a Founding Partner of Mojo Ventures, a unique late-stage company builder focused on working with startups and small companies to achieve unprecedented growth and profitability.  Before being an entrepreneur, Andres was President/CEO at IQ Outsourcing, a leading Colombian Business Process Outsourcing Firm that is part of the Sanford Group of Companies. Prior to joining IQ, Andres was a Principal Member at Booz & Company, a management consulting firm, based in Mexico City. Sponsored by Booz Allen in recognition of the performance during the three previous years working with the firm, Andres obtained an MBA at HARVARD BUSINESS SCHOOL. He is B.S. Industrial Engineering and B.S. Economics from Los Andes University in Colombia of which he graduated with honors (top 3% of the class).

    KYLE DETWILER

    CEO - Chief Executive Officer

    Kyle Detwiler is CEO of Clever Leaves. Prior to the integration of Northern Swan and Clever Leaves in 2019, Detwiler served as CEO and co-founder of Northern Swan Holdings as well as co-founded Silver Swan Capital, an investment firm focused on niche and underfollowed sectors. He was also a Principal at The Blackstone Group, a leading alternative investment manager with $472 billion in assets under management. As an early member of the Tactical Opportunities Fund, Detwiler was involved in the management and served as a board member of seven investments with roughly $1 billion of Blackstone capital. Detwiler was previously a member of the private equity practice at KKR, focusing on transactions in the oil and gas, energy, natural resource and health care sectors. He began his career as an investment banker at Morgan Stanley. Detwiler graduated with distinction from Harvard Business School and cum laude from Princeton University.

    JULIÁN WILCHES

    CRO - Chief Regulatory Officer

    Julian is Clever Leaves’ Chief Regulatory Officer. In this position Julian is in charge of structuring and maintaining the company’s relationship strategies and policies with different stakeholders of interest, including governments, regulators and communities. Julián acted as Director of Drug Policy for the Colombian Ministry of Justice and Law (2011-2014) and was Advisor on the Presidential Programme against Illicit Crops (2005-2007). He was also the Deputy Director of Interinstitutional Articulation at the Attorney General’s Office (June 2014-Dec 2015). Additionally, Julian served as a Consultant and Advisor to the Ministry of Culture (2003-2005), the Colombian Institute for Rural Development – Incoder, and the “Coordination of the Culture of Law” Project – NSIC (2007-2008). Julian has a B.A. in Political Science from Los Andes University (Bogotá, Colombia) and a Master’s in journalism from Alcalá de Henares University (Madrid, Spain).